Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term intensity-modulated radiotherapy. Found 8 abstracts

Shaikh T, Meyer JE, Horwitz EM. Optimal Use of Combined Modality Therapy in the Treatment of Esophageal Cancer. Surg Oncol Clin N Am. 2017 Jul;26(3):405-29.   PMCID: REVIEW
Ettinger DS, Akerley W, Borghaei H, Chang A, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Ganti AK, Govindan R, Grannis FW, Horn L, Jahan TM, Jahanzeb M, Kessinger A, Komaki R, Kong FM, Kris MG, Krug LM, Lennes IT, Loo BW, Martins R, O'Malley J, Osarogiagbon RU, Otterson GA, Patel JD, Pinder-Schenck M, Pisters KM, Reckamp K, Riely GJ, Rohren E, Swanson SJ, Wood DE, Yang SC. Malignant Pleural Mesothelioma. Journal of the National Comprehensive Cancer Network. 2012 Jan;10(1):26-41.   PMCID: not NIH funded
Pahlajani N, Ruth KJ, Buyyounouski MK, Chen DY, Horwitz EM, Hanks GE, Price RA, Pollack A. RADIOTHERAPY DOSES OF 80 GY AND HIGHER ARE ASSOCIATED WITH LOWER MORTALITY IN MEN WITH GLEASON SCORE 8 TO 10 PROSTATE CANCER. International Journal of Radiation Oncology Biology Physics. 2012 Apr;82(5):1949-56.   PMCID: PMC3827957
Xu QY, Chen Y, Grimm J, Fan JJ, An LL, Xue JY, Pahlajani N, LaCouture T. Dosimetric investigation of accelerated partial breast irradiation (APBI) using CyberKnife. Medical Physics. 2012 Nov;39(11):6621-8.   PMCID: not NIH funded
Ajani JA, Barthel JS, Bentrem DJ, D'Amico TA, Das P, Denlinger CS, Fuchs CS, Gerdes H, Glasgow RE, Hayman JA, Hofstetter WL, Ilson DH, Keswani RN, Kleinberg LR, Korn M, Lockhart AC, Mulcahy MF, Orringer MB, Osarogiagbon RU, Posey JA, Sasson AR, Scott WJ, Shibata S, Strong VE, Varghese TK, Warren G, Washington MK, Willett C, Wright CD, Meron Aj VP. Esophageal and Esophagogastric Junction Cancers. Journal of the National Comprehensive Cancer Network. 2011 Aug;9(8):830-+.   PMCID: not NIH funded
Small W, Mell LK, Anderson P, Creutzberg C, De Los Santos J, Gaffney D, Jhingran A, Portelance L, Schefter T, Iyer R, Varia M, Winter K, Mundt AJ. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer. International Journal of Radiation Oncology Biology Physics. 2008 Jun;71(2):428-34.
Pollack A, Hanlon AL, Horwitz EM, Feigenberg SJ, Konski AA, Movsas B, Greenberg RE, Uzzo RG, Ma CM, McNeeley SW, Buyyounouski MK, Price RA. Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2006 Feb;64(2):518-26.
Price RA, Hannoun-Levi JM, Horvvitz E, Buyyounouski M, Ruth KJ, Ma CM, Pollack A. Impact of pelvic nodal irradiation with intensity-modulated radiotherapy on treatment of prostate cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2006 Oct;66(2):583-92.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term intensity-modulated radiotherapy

intensity-modulated radiotherapy radiation-therapy phase-iii trial NCCN Clinical Practice Guidelines squamous-cell carcinoma surgery high-grade dysplasia NCCN Guidelines Oncology toxicity distant metastases conformal radiation-therapy carcinoma chemoradiation Nuclear Medicine & Medical Imaging Radiology imrt randomized controlled-trial chemotherapy positron-emission-tomography ACUTE HEMATOLOGIC TOXICITY biologic therapy androgen volume esophageal conserving surgery target volume EXTENDED-FIELD whole pelvic radiotherapy malignant pleural dose hemithoracic radiation IMRT reduction dosimetry pelvic therapy High grade alpha 70 gy late rectal toxicity long-term survival organ CyberKnife APBI-planning 1995 ow wh-v274-p474 controlled-trial multicenter phase-ii hypofractionation CARCINOMA Radiation adjuvant therapy RADIATION-THERAPY clinically localized adenocarcinoma escalation trial 20-year asbestos IMPACT BONY LANDMARKS mesothelioma potentiating factor esophageal cancer arbeitsgemeinschaft internistische onkologie MALIGNANCIES Survival 3-dimensional conformal radiotherapy randomized-trial rectum cervical cancer megakaryocyte cancer dose-escalation preservation resection extrapleural pneumonectomy local recurrences esophagectomy radiotherapy follow-up endometrial cancer small-bowel randomized minimally invasive esophagectomy pemetrexed plus cisplatin trimodality conformal radiotherapy pelvic lymphatics neoadjuvant chemoradiotherapy competing risk beta-ratio suppression fractionation 10-year trimodality therapy ADJUVANT TREATMENT radiation therapy combined modality therapy pathological complete response expanded access program endoscopic mucosal resection term-follow-up multidisciplinary care GYNECOLOGIC mastectomy IRRADIATION segment phase-ii trial trial MARROW Dose escalation pleural effusion combined-modality defining biochemical failure
Last updated on Monday, August 10, 2020